Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2045
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pnd117 - Physician Reported Adherence in Ms Patients Treated With Injectable Platform Therapies Versus Delayed-Release Dimethyl Fumarate: Findings From a Real-World Cross-Sectional Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Retrospective Analysis of Real-World Discontinuation Rates With Delayed-Release Dimethyl Fumarate in Patients With Relapsing–Remitting Multiple Sclerosis

Neurology and Therapy
Neurology
2019English

Healthcare Utilisation for Eating Disorders Among Patients With Depression: A Cross-Sectional Study in Taiwan

BMJ Open
Medicine
2019English

Real-World Two-Year Treatment Patterns Among Patients With Psoriatic Arthritis Treated With Injectable Biologic Therapies

Current Medical Research and Opinion
Medicine
2020English

Pnd8 - Peginterferon Beta-1a Is Associated With Reduced Relapse Rates and Hospitalisations Due to Relapse Compared With Other First-Line Injectable Therapies for Multiple Sclerosis: Findings From a Real-World Cross-Sectional Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pathways of Healthcare Utilisation in Patients With Suspected Adolescent Idiopathic Scoliosis: A Cross-Sectional Study

BMC Health Services Research
Health Policy
2015English

Patient-Specific Factors Modulate Leukocyte Response in Dimethyl Fumarate Treated MS Patients

PLoS ONE
Multidisciplinary
2020English

Consensus Management of Gastrointestinal Events Associated With Delayed-Release Dimethyl Fumarate: A Delphi Study

Neurology and Therapy
Neurology
2015English

Pgi52 - Decreased Work Productivity and Increased Healthcare Resource Utilisation (Hru) Among Patients With Non-Alcoholic Steatohepatitis (Nash) – Results From a Real World Evidence Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy